Skip to main content
. 2018 May 2;3(7):591–600. doi: 10.1001/jamacardio.2018.1049

Table 2. Absolute Risk of Sudden and/or Arrhythmic Death (SAD) and Competing Modes of Death.

Clinical Subgroup Patients in Subgroup, No. (%) 4-y Incidence SAD (95% CI) P Valuea 4-y Incidence Non-SAD (95% CI) P Valuea
Age, y
≤59 1882 (33) 2.0 (1.4-2.8) .05 2.1 (1.4-2.9) <.001
60-69 1990 (35) 1.6 (1.1-2.2) 5.6 (4.5-6.9)
>69 1889 (33) 2.9 (2.1-3.8) 15.2 (13.5-17.1)
Sex
Male 4391 (76) 2.2 (1.8-2.7) .91 7.4 (6.6-8.3) .21
Female 1370 (24) 2.0 (1.3-2.9) 8.7 (7.1-10.6)
Race/ethnicity
White 5128 (89) 2.2 (1.8-2.6) .88 7.9 (7.1-8.8) .31
Other 633 (11) 2.2 (1.1-3.8) 6.2 (4.3-8.5)
Smoking
Never 1945 (34) 1.8 (1.2-2.5) .27 6.3 (5.1-7.5) .05
Ever 3814 (66) 2.4 (1.9-2.9) 8.5 (7.5-9.5)
Hypertension
Yes 4371 (76) 2.4 (1.9-2.9) .04 8.5 (7.6-9.5) <.001
No 1390 (24) 1.4 (0.8-2.2) 5.3 (4.1-6.8)
History of revascularization
Yes 5328 (92) 2.2 (1.8-2.6) .93 7.5 (6.7-8.3) .02
No 433 (8) 2.0 (0.9-3.7) 10.6 (7.7-14.1)
Family history sudden cardiac death
Yes 1432 (25) 2.5 (1.7-3.5) .25 8.0 (6.5-9.8) .79
No 4329 (75) 2.0 (1.6-2.5) 7.6 (6.8-8.5)
Diabetes mellitus
Yes 1860 (32) 3.3 (2.5-4.3) <.001 11.4 (9.8-13.1) <.001
No 3901 (68) 1.6 (1.2-2.1) 6.0 (5.2-6.9)
Atrial fibrillation
Yes 791 (14) 3.8 (2.6-5.5) .003 15.7 (13.0-18.7) <.001
No 4969 (87) 1.9 (1.5-2.3) 6.4 (5.7-7.2)
Left ventricular ejection fraction, %
≥60 1591 (28) 1.0 (0.5-1.6) <.001 5.2 (4.1-6.6) <.001
50-59 1997 (35) 1.6 (1.1-2.3) 6.4 (5.2-7.7)
40-49 1756 (30) 3.2 (2.4-4.2) 10.1 (8.6-11.7)
30-39 417 (7) 4.9 (3.0-7.6) 14.5 (10.8-18.6)
New York Heart Association class
I 4597 (80) 2.0 (1.6-2.5) .02 6.3 (5.5-7.1) <.001
II 925 (16) 2.1 (1.2-3.4) 12.6 (10.3-15.1)
III/IV 223 (4) 5.1 (2.6-8.9) 17.8 (12.4-24.0)
a

The P value reflects the Gray test for equivalence of cumulative incidence functions across specified strata. Competing deaths (non-SAD) include nonsudden, nonarrhythmic cardiovascular deaths, noncardiovascular deaths, and unclassified deaths.